The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Seminar Title
Seminar Therapeutic 3 : Can European wide hospital pharmacy standards work in reality? A practical example from the world of paediatrics.
Affiliation
Royal Pharmaceutical Society
Country
United Kingdom
1. Current Status, Position
Dr Catherine Duggan is the Director of Professional Development and Support at the Royal Pharmaceutical Society of Great Britain. In her role, she is responsible for the delivery of professional advice and support to all members across all sectors, alongside the development of strategies to share and showcase good practice as well as developing professional standards for practice. She has a leadership role in developing programmes of professional development, advancement and recognition in line with the RPS mission, including the development and delivery of the RPS Faculty in 2013.
Catherine has worked in community, hospital and academia. Between 1999 and 2009, she held joint appointments between clinical practice and academia in roles that supported professional development and evidence based practice as well as developing courses and support alongside supporting research and evaluations at all levels of practice. She has published widely and presented at national and international meetings. Catherine was the Chair of the United Kingdom Clinical Pharmacy Association for 2007 to 2009 and an elected member of the Council of the RPSGB between 2008 and 2009. She is a Fellow of both the RPSGB and the Royal Society of Arts.
2. Education
Support for advanced practice; clinical pharmacy; undergraduate and postgraduate formal courses; UKCPA and RPS; 10 years and supervising doctoral/MSc projects.
3. Research Area
Her current areas of research include:
• Communication between primary and secondary care – both GB and Europe wide
• Risk management of high risk patients and admissions
• Information to patients to improve adherence
• Risk management of high risk patients and admissions
• Information to patients to improve adherence